Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Kicks Off Pharmaceutical Manufacturing And Innovation Project

This article was originally published in PharmAsia News

Executive Summary

A task force comprising members from China's Ministry of Health and 10 governmental bodies has proposed pharmaceutical manufacturing and innovation guidelines under the national science and technology development program. The project has two key targets, first of which is the development of a batch of medical products that are safe, efficient, convenient and cheap to prevent and treat major diseases. The second is the development of innovative drugs with intellectual property rights and market competitiveness, building up of advanced technology platforms, as well as shaping new drug creativity and technology systems to support the nation's pharmaceutical innovation. (Click here for more - Chinese Language)
Advertisement
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

SC069727

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel